Healius (ASX:HLS) has spent the past 18 months shrinking itself back to a single idea. The imaging arm is gone, the corporate centre has been cut, and what remains is one of Australia’s two national pathology networks running on thin margins. On 19 August 2026 the company will put a full year of that reset on the table.

The stock price was in the spotlight after its share price recorded a significant jump. Healius confirmed the timing of its FY26 results in an ASX announcement lodged on 30 July 2026, following a difficult 12 months for shareholders.

What happened?

The defining event of the past year was not a result but a downgrade. On 13 May 2026, Healius issued a trading update for FY26…